HUP0402673A2 - Erekciózavar kezelésére szolgáló prosztaglandin készítmény - Google Patents

Erekciózavar kezelésére szolgáló prosztaglandin készítmény

Info

Publication number
HUP0402673A2
HUP0402673A2 HU0402673A HUP0402673A HUP0402673A2 HU P0402673 A2 HUP0402673 A2 HU P0402673A2 HU 0402673 A HU0402673 A HU 0402673A HU P0402673 A HUP0402673 A HU P0402673A HU P0402673 A2 HUP0402673 A2 HU P0402673A2
Authority
HU
Hungary
Prior art keywords
stimulus
preparation
treatment
erectile dysfunction
group containing
Prior art date
Application number
HU0402673A
Other languages
English (en)
Inventor
Koichi Okada
James L. Yeager
Nadir Büyüktimkin
Servet Büyüktimkin
Original Assignee
Nexmed (Holdings), Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed (Holdings), Inc. filed Critical Nexmed (Holdings), Inc.
Publication of HUP0402673A2 publication Critical patent/HUP0402673A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát képező készítmény alkalmas erekciózavarkezelésére, oly módon, hogy a makk vérkeringését hatékonyan fokozómennyiségű félkemény vazoaktív prosztaglandin készítményt a páciensfossa navicularisába helyeznek, amely készítmény az alábbiakattartalmazza: - vazoaktív prosztaglandin; - penetráció elősegítő szer;- polimer, ami a poliszacharid gumikat és poliakrilsav polimerekettartalmazó csoportból választott; - lipofil komponens, ami az alifásC1 - C8 alkoholokat és alifás C8 - C30 észtereket és keverékeikettartalmazó csoportból választott; - savas pufferrendszer; és legalábbegy erotikus ingert szolgáltatnak, ami az alábbiakat tartalmazócsoportból választott: szaginger, vizuális inger, hanginger éstapintás. Ó
HU0402673A 2002-02-15 2003-02-14 Erekciózavar kezelésére szolgáló prosztaglandin készítmény HUP0402673A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35728202P 2002-02-15 2002-02-15
PCT/US2003/004560 WO2003070281A1 (en) 2002-02-15 2003-02-14 Prostaglandin composition for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
HUP0402673A2 true HUP0402673A2 (hu) 2005-04-28

Family

ID=27757591

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402673A HUP0402673A2 (hu) 2002-02-15 2003-02-14 Erekciózavar kezelésére szolgáló prosztaglandin készítmény

Country Status (13)

Country Link
US (1) US20030220292A1 (hu)
EP (1) EP1482980A1 (hu)
JP (1) JP2005517725A (hu)
KR (1) KR20040082431A (hu)
CN (1) CN1610559A (hu)
AU (1) AU2003211077A1 (hu)
BR (1) BR0307345A (hu)
CA (1) CA2468631A1 (hu)
HU (1) HUP0402673A2 (hu)
IL (1) IL162154A0 (hu)
MX (1) MXPA04007828A (hu)
WO (1) WO2003070281A1 (hu)
ZA (1) ZA200404105B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
JP2006512291A (ja) * 2002-09-06 2006-04-13 ネックスメド ホールディングス インコーポレイテッド 男性***障害の治療方法
JP2006520788A (ja) * 2003-03-21 2006-09-14 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物による血管形成促進および方法
KR101086147B1 (ko) 2003-03-21 2011-11-25 넥스메드 홀딩스 인코포레이티드 조루증 치료용 조성물 및 치료 방법
US7623923B2 (en) * 2005-04-28 2009-11-24 Medtronic, Inc. Tube sensor for penile tumescence
US8068910B2 (en) * 2005-04-28 2011-11-29 Medtronic, Inc. Flexible tube sensor for sensing urinary sphincter pressure
US7610093B2 (en) * 2005-04-28 2009-10-27 Medtronic, Inc. Implantable optical pressure sensor for sensing urinary sphincter pressure
US7328070B2 (en) 2005-04-28 2008-02-05 Medtronic, Inc. Multi-tube sensor for sensing urinary sphincter and urethral pressure
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
US20100184722A1 (en) * 2008-12-19 2010-07-22 Shimoda Biotech (Pty) Ltd Inclusion complexes of alpha-cyclodextrin and sildenafil salt
CN109999359B (zh) * 2019-01-24 2021-08-13 西安蓝极医疗电子科技有限公司 基于多波长激光治疗男性***功能障碍的装置
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种***中与无***症有关的分子标志物及其检测方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595975A (en) * 1969-07-29 1971-07-27 Holliston Lab Inc Disinfecting compositions
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
NZ331549A (en) * 1996-01-29 2000-09-29 Univ California Compounds useful in treating sexual dysfunction
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6414028B1 (en) * 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6486207B2 (en) * 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction

Also Published As

Publication number Publication date
JP2005517725A (ja) 2005-06-16
CN1610559A (zh) 2005-04-27
AU2003211077A1 (en) 2003-09-09
ZA200404105B (en) 2005-08-26
WO2003070281A1 (en) 2003-08-28
MXPA04007828A (es) 2004-10-15
US20030220292A1 (en) 2003-11-27
CA2468631A1 (en) 2003-08-28
IL162154A0 (en) 2005-11-20
KR20040082431A (ko) 2004-09-24
BR0307345A (pt) 2004-12-14
EP1482980A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
Scully et al. Tongue piercing (oral body art)
HUP0402673A2 (hu) Erekciózavar kezelésére szolgáló prosztaglandin készítmény
WO2002072172A3 (en) Apparatus and methods for capture of medical agents
HUP0002755A2 (hu) Eljárások szklerózis multiplexben szenvedő betegek kezelésére konszenzus interferonnal
HUP0001089A2 (hu) Gyógyászati készítmények férfiak erekciós zavarainak kezelésére
CY1108745T1 (el) Πεπτιδια δια τη θεραπευτικη αγωγη κακης συμπεριφορας μεταξυ προσωπων
WO2004053770A3 (en) A system for analyzing and processing orders related to healthcare treatment or services
HUP0103206A2 (hu) Merevedési zavarok kezelésére szolgáló eszköz és eljárás az előállítására
PL324424A1 (en) Therapeutic factors and autoimmunological diseases
HUP0204048A2 (hu) Dezloratadin alkalmazása allergiás és gyulladásos tünetek kezelésére
HUP0102987A2 (hu) Hatóanyagként asztrocita funkciójavító szert tartalmazó készítmény Parkinson-kór kezelésére
MD2323G2 (ro) Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin
Zengin Mandibular mesiodens
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
MD1732F1 (en) Method of prognosticating the duodenal ulcerous disease evolution
CN201200609Y (zh) 治疗腰部疲劳的腰带
HUP0401041A2 (hu) Renin-angiotenzin rendszer inhibitor alkalmazása lipodisztrófia kezelésére alkalmas gyógyszerkészítmény előállítására
Bhat Internet revolution
Trenouth Undefined relationships
FR2846658B1 (fr) Peptides pour la prevention, le diagnostic et le traitement de la leptospirose animale et/ou humaine.
Morganstein One-stop-shop
Isaacs Critical reading
Cooper Cornerstone of surgery
Gankerseer Distress in the detail
Graham et al. Access to the chin

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees